Evidence map›Paper›PMID 28443990›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2017

MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.

L Song, P Duan, Y Gan, P Li, C Zhao, J Xu, Z Zhang, Q Zhou

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. miR-340: A multifunctional role in human malignant diseases.International journal of biological sciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

L SongDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
P DuanSouthwest Eye Hospital, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
Y GanDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
P LiDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
C ZhaoDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
J XuDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
Z ZhangDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
Q ZhouDepartment of Orthopedics, First Affiliated Hospital, Third Military Medical University, Chongqing, China.
Southwest Hospital · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) play an important role in drug resistance and modulate the efficiency of chemotherapy. A recent study indicated that miR-340 functions as a tumor suppressor in various types of cancer. However, the role of miR-340 in chemotherapy has not been reported yet. In this study, we found that miR-340 enhanced cisplatin (CDDP)-induced cell death. Induction of miR-340-5p expression decreased the IC50 of CDDP and increased the apoptosis of CDDP-resistant MG-63 and Saos-2 cells. Moreover, miR-340-5p decreased the accumulation of MRP1 and MDR1. We further explored the mechanism underlying the promoting effects of miR-340-5p on CDDP-induced cell death. We identified a potential target of miR-340 in the 3' untranslated region of lysophosphatidic acid acyltransferase (LPAATβ) using the online program Targetscan (http://www.microrna.org). Luciferase reporter assays showed that miR-340 binds to the 3'UTR of LPAATβ. Enforced expression of miR-340-5p decreased the accumulation of LPAATβ in both MG-63 and Saos-2 cells. Silencing LPAATβ decreased the IC50 of CDDP and increased the apoptosis of CDDP-resistant MG-63 and Saos-2 cells, which is consistent with the effect of miR-340-5p on CDDP-induced cell death. Moreover, induced expression of LPAATβ compromised the effects of miR-340-5p on CDDP-induced cell death and accumulation of MRP1 and MDR1. Taken together, our data indicated that miR-340-5p enhanced the sensitivity to CDDP by targeting LPAATβ.

Indexed as

AcyltransferasesAntineoplastic AgentsApoptosisBlotting, WesternBone NeoplasmsCell Line, TumorCell ProliferationCisplatinDown-RegulationDrug Resistance, NeoplasmHumansLuciferasesMicroRNAsOsteosarcomaReal-Time Polymerase Chain Reaction2-acylglycerophosphate acyltransferaseAcyltransferasesAntineoplastic AgentsCisplatinLuciferasesMicroRNAsMIRN340 microRNA, human

Identifiers

PMID28443990
PMCPMC5441287
OpenAlexW2606385901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.